Plus therapeutics announces private placement financing of up to $18 million

Austin, texas, may 06, 2024 (globe newswire) -- plus therapeutics, inc. (nasdaq:  pstv ) (the “company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (cns) cancers, today announced that it has entered into a securities purchase agreement with new institutional investors and company insiders to raise up to approximately $18 million in gross proceeds, including initial upfront funding of approximately $6.5 million, and up to an additional approximately $11.5 million upon cash exercise of accompanying warrants at the election of the investors. the financing includes participation from aigh capital management llc with additional participation from new healthcare-focused institutional investors as well as certain company insiders.
PSTV Ratings Summary
PSTV Quant Ranking